These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 1694582)
1. Disposition characteristics of macromolecules in tumor-bearing mice. Takakura Y; Fujita T; Hashida M; Sezaki H Pharm Res; 1990 Apr; 7(4):339-46. PubMed ID: 1694582 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting. Nishikawa M; Kamijo A; Fujita T; Takakura Y; Sezaki H; Hashida M Pharm Res; 1993 Sep; 10(9):1253-61. PubMed ID: 7694271 [TBL] [Abstract][Full Text] [Related]
3. Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors. Kissel M; Peschke P; Subr V; Ulbrich K; Schuhmacher J; Debus J; Friedrich E PDA J Pharm Sci Technol; 2001; 55(3):191-201. PubMed ID: 11417110 [TBL] [Abstract][Full Text] [Related]
4. Tissue distribution of 111In-labeled uricase conjugated with charged dextrans and polyethylene glycol. Fujita T; Yasuda Y; Takakura Y; Hashida M; Sezaki H J Pharmacobiodyn; 1991 Nov; 14(11):623-9. PubMed ID: 1725532 [TBL] [Abstract][Full Text] [Related]
5. Disposition characteristics of mitomycin C-dextran conjugate in normal and tumor-bearing muscles of rabbits. Atsumi R; Endo K; Kakutani T; Takakura Y; Hashida M; Sezaki H Cancer Res; 1987 Nov; 47(21):5546-51. PubMed ID: 2444332 [TBL] [Abstract][Full Text] [Related]
6. Carrier and dose effects on the pharmacokinetics of T-0128, a camptothecin analogue-carboxymethyl dextran conjugate, in non-tumor- and tumor-bearing rats. Harada M; Murata J; Sakamura Y; Sakakibara H; Okuno S; Suzuki T J Control Release; 2001 Mar; 71(1):71-86. PubMed ID: 11245909 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and disposition characteristics of recombinant decorin after intravenous injection into mice. Masuda H; Takakura Y; Hashida M Biochim Biophys Acta; 1999 Feb; 1426(3):420-8. PubMed ID: 10076058 [TBL] [Abstract][Full Text] [Related]
8. Control of in vivo fate of albumin derivatives utilizing combined chemical modification. Fujita T; Nishikawa M; Ohtsubo Y; Ohno J; Takakura Y; Sezaki H; Hashida M J Drug Target; 1994; 2(2):157-65. PubMed ID: 8069594 [TBL] [Abstract][Full Text] [Related]
9. Biliary excretion of mitomycin C dextran conjugates in relation to physicochemical characteristics of carrier dextran. Hashida M; Atsumi R; Nishida K; Nakane S; Takakura Y; Sezaki H J Pharmacobiodyn; 1990 Jul; 13(7):441-7. PubMed ID: 1705289 [TBL] [Abstract][Full Text] [Related]
10. Disposition characteristics of model macromolecules in the perfused rat kidney. Mihara K; Mori M; Hojo T; Takakura Y; Sezaki H; Hashida M Biol Pharm Bull; 1993 Feb; 16(2):158-62. PubMed ID: 7689886 [TBL] [Abstract][Full Text] [Related]
11. Disposition and tumor localization of mitomycin C-dextran conjugates in mice. Takakura Y; Takagi A; Hashida M; Sezaki H Pharm Res; 1987 Aug; 4(4):293-300. PubMed ID: 2470072 [TBL] [Abstract][Full Text] [Related]
12. Polysaccharides as drug carriers: biodisposition of fluorescein-labeled dextrans in mice. Kaneo Y; Uemura T; Tanaka T; Kanoh S Biol Pharm Bull; 1997 Feb; 20(2):181-7. PubMed ID: 9057983 [TBL] [Abstract][Full Text] [Related]
13. Disposition characteristics of recombinant human interleukin-11 after a bolus intravenous administration in mice. Takagi A; Masuda H; Takakura Y; Hashida M J Pharmacol Exp Ther; 1995 Nov; 275(2):537-43. PubMed ID: 7473136 [TBL] [Abstract][Full Text] [Related]
14. Disposition characteristics of macromolecules in the perfused tissue-isolated tumor preparation. Imoto H; Sakamura Y; Ohkouchi K; Atsumi R; Takakura Y; Sezaki H; Hashida M Cancer Res; 1992 Aug; 52(16):4396-401. PubMed ID: 1379513 [TBL] [Abstract][Full Text] [Related]
15. Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver. Nishida K; Mihara K; Takino T; Nakane S; Takakura Y; Hashida M; Sezaki H Pharm Res; 1991 Apr; 8(4):437-44. PubMed ID: 1714579 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors. Yamasaki Y; Sumimoto K; Nishikawa M; Yamashita F; Yamaoka K; Hashida M; Takakura Y J Pharmacol Exp Ther; 2002 May; 301(2):467-77. PubMed ID: 11961045 [TBL] [Abstract][Full Text] [Related]
17. Demonstration of the receptor-mediated hepatic uptake of dextran in mice. Nishikawa M; Yamashita F; Takakura Y; Hashida M; Sezaki H J Pharm Pharmacol; 1992 May; 44(5):396-401. PubMed ID: 1279155 [TBL] [Abstract][Full Text] [Related]
18. Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats. Staud F; Nishikawa M; Morimoto K; Takakura Y; Hashida M J Pharm Sci; 1999 Jun; 88(6):577-85. PubMed ID: 10350492 [TBL] [Abstract][Full Text] [Related]
19. The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake. Kawabata K; Takakura Y; Hashida M Pharm Res; 1995 Jun; 12(6):825-30. PubMed ID: 7667185 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts. Longley C; Furmanski P; Dienhart DG; Lear J; Bloedow D; Kasliwal R; Bunn PA Cancer Res; 1990 Sep; 50(18):5954-61. PubMed ID: 2393864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]